🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

👀The first Immuno-Oncology Session coming in hot at #Multiomics2024! Such amazing talks from Anand Jeyasekharan (Anand D Jeyasekharan), Tullia Bruno (Tullia Bruno, PhD), Ram Dasgupta (Ramanuj Dasgupta), & Fei Yang (Dr Fei Yang). 😍It was an honor to chair, alongside the wonderful Jessica Duarte.

Anand D Jeyasekharan

The person at Apple who designed the new layout for the photos app should be imprisoned

SNL did good on this one, not gonna lie.

It's an absolute scandal and tragedy that India is forced to spend $250m/year to provide access to the latest science to its people. A complete and total failure of global science leadership and of science writ large.

What with the fall of Aleppo, the imminent end of the essential pastime of skiing due to global warming, and the possibility that the Russians own the guy who owns X, I’ve opened an account on @Bluesky. bsky.app/profile/jamesb…

just 2 dudes in 2003 not realizing they just made one of the best songs ever x.com/copiumx/status…

The dysfunction and corruption in science publishing has been so normalized that there are lots of people on here sincerely arguing that this is a good deal.

“My name is Amos Goldberg. I am an Israeli Professor of Holocaust Studies. For nearly 30 years I have researched and taught the Holocaust, genocide and state violence. And I want to tell whoever is willing to listen that what’s happening now in Gaza is a genocide. A year ago

Wow! Dr. Druker resigns. This is the Dr. Brian Druker! Academic medicine has a problem. I hear this sentiment from many investigators. wweek.com/news/2024/12/0…

Our paper on single-cell splicing QTL is now published as a cover article in Nature Genetics. nature.com/articles/s4158… Congratulations to co-first authors Tian Chi, Yihan, and Yuntian Zhang! Huge thanks to AIDA leaders Shyam Prabhakar Lab , Woong-Yang, JayShin and Kian Hong!

It's exciting to see our field getting the spotlight and recognition it deserves. Great work by the editors and all of the authors involved!! But I wonder if we need to reconsider the general term that is used for these methods ... "spatial proteomics" I don't view our

Very cool abstract by ADJ lab CSI Singapore Anand D Jeyasekharan ATR inhibition with gemcitabine suppresses a BCL6-regulated transcriptional program, reversing dark zone signature in DLBCL ashpublications.org/blood/article/…

Artificial Incarnation Michael Eisen Not sure anything good has been written about it. We tried to turn a journal with a good reputation into a preprint review service, eliminating accept/reject decisions, and replacing with public reviews + a concise editorial assessment highlighting the strength of support and

Updates from a hobby researcher. No grants/affiliations/backing/dedicated research team. 100% clinical practice. Thank you for all the collaborators. Shows what we can do if we join hands and share our experiences.

🧵 Finally had a chance to dig into DeepSeek’s r1… Let me break down why DeepSeek's AI innovations are blowing people's minds (and possibly threatening Nvidia's $2T market cap) in simple terms...

Too Real 😭😭😭

🔥 Interesting pre-print on how Chk1-Sp1-CD59 axis impedes rituximab mediated complement-dependent cytotoxicity biorxiv.org/content/10.110… Congratulations to the team! Anand D Jeyasekharan [email protected] NCIS CSI Singapore Chng Wee Joo

🚀 We're hiring! Join the Casola & Tripodo Labs at IFOM as a Bioinformatics Data Analyst! 🔬 RNA-seq, TCR genetics, spatial omics. 📍 Position Based in Catania, collaborating with IFOM wet labs in Milan. 🧬 PhD/MSc in bioinformatics required. To apply: [email protected]

🧬 The Chk1-Sp1-CD59 axis weakens rituximab ability to kill lymphoma cells by impairing Complement-dependent cytotoxicity. Targeting this pathway could enhance chemoimmunotherapy outcomes. CSI Singapore Anand D Jeyasekharan 🔬#Complement #Immunotherapy #DLBCL Link: doi.org/10.1101/2025.0…